BCL2 and breast cancer: Similarly, PGC1α silencing significantly increased the levels of apoptosis markers (BAX, cytochrome c, caspase-9, cleaved caspase-9, and caspase-3) and decreased Bcl-2 and PARP1 expression in both BC cell lines (Figure 6C,D).